Algalif Achieves Novel Food Certification for Astalif Natural Astaxanthin

Algalif, Icelandic producer of pure, high-grade, natural astaxanthin from microalgae, today announced that its Astalíf™ Astaxanthin has received Novel Food approval from the European Commission as a food supplement ingredient, confirming the consumer safety of the product for the European market.

After extensive evaluation, the European Commission and The Food Safety Authority of Iceland certified that Astalif™ meets or exceeds all requirements for an ingredient in food supplements, in a manner that is consistent with the current uses and use levels of astaxanthin-rich oleoresins from Haematococcus pluvialis, and concluded that the ingredient is approved for commercial availability.

“This certification marks a significant milestone for Algalif and represents an important step in our steadfast commitment to quality and purity,” said Andrew Jacobson, CEO of Algalif. “The Novel Food certification comes on the heels of gaining cGMP status for our world-class production facility. I commend our Icelandic team led by Orri Björnsson for its ongoing, rigorous efforts in achieving these important industry certifications.”

About Algalif
Algalif is a high-grade microalgae ingredient supplier from Iceland. We are dedicated to solving the nutritional needs of current and future generations through the development and delivery of sustainable, high-quality microalgae. Astalíf™ Astaxanthin is our first step in this journey. Algalif is a part of Sana Pharma, an international company founded in 2002 with businesses in food supplements, specialty ingredients, medical devices and over-the-counter medicines. Sana Pharma is established in Norway, Sweden, Denmark, Finland, Iceland, the Czech Republic and the United States, with more than 200 employees.

Contacts

Heidi Rosenberg, Senior Public Relations Counsel, BrandHive, +1 385-222-7043, +1 435-841-2171, heidi@brandhive.com